Want to join the conversation?
Wendy Nicholson from Citi Research asks about China more broadly. $PG CFO Jon Moeller said that that middle of the portfolio is very important & the company is not losing site of that. The company wants to take advantage of the higher growth portion of the market, currently the premium tiers. So it's clearly an "and" strategy not an "or" strategy.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?